Combination of antiplatelet and anticoagulant therapy, component network meta-analysis of randomized controlled trials

L Szapáry, D Tornyos, P Kupó, R Lukács… - Frontiers in …, 2022 - frontiersin.org
Background Despite numerous randomized clinical trials (RCT), data regarding the efficacy
of antiplatelet and anticoagulant combinations are still conflicting. We aimed to analyze …

[HTML][HTML] Efficacy and safety of direct oral anticoagulants with and without Aspirin: A systematic review and Meta-analysis

T Almas, A Musheer, A Ejaz, FN Shaikh… - IJC Heart & …, 2022 - Elsevier
Background Various anticoagulant therapies are prescribed to patients under physicians'
discretion and recently Direct Oral Anticoagulants (DOAC) have been under trials to …

Pro-Con Debate: Are Patients With Coronary Stents Suitable for Free-Standing Ambulatory Surgery Centers?

EB Rosero, N Rajan, GP Joshi - Anesthesia & Analgesia, 2023 - journals.lww.com
With increasing implantation of coronary artery stents over the past 2 decades, it is inevitable
that anesthesiologists practicing in the outpatient setting will need to determine whether …

[HTML][HTML] Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease with recent or remote events: Systematic review and meta-analysis

A Hayek, BJ MacDonald, G Marquis-Gravel, KR Bainey… - CJC open, 2024 - Elsevier
Background Ongoing debate remains regarding optimal antithrombotic therapy in patients
with atrial fibrillation (AF) and coronary artery disease (CAD). Methods We performed a …

An update on antithrombotic therapy in atrial fibrillation patients in long-term ambulatory setting after percutaneous coronary intervention: where do we go from here?

J Marazzato, P Verdecchia, M Golino… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction In the treatment of patients with atrial fibrillation (AF) who undergo percutaneous
coronary intervention (PCI), it is unclear which combination of antithrombotic drugs is …